Effect of the bio-inspired modification of low-cost membranes with TiO2:ZnO as microbial fuel cell membranes.

Microbial fuel cells (MFCs) are a novel technique for converting biodegradable materials into electricity. In this study, the efficiency of mixed crystal (TiO2:ZnO) as a membrane modifier of a low-cost, antifouling and self-cleaning cation exchange membrane for MFCs was studied. The modification was prepared using polydopamine (PDA) as the bio-inspired glue, followed by gravity deposition of a mixture of catalyst nanoparticles (TiO2:ZnO 0.03%, 1:1 ratio) as anti-biofouling agents. The effects of the membrane modification were evaluated in terms of power density, open circuit potential, coulombic efficiency, anti-biofouling properties and also color and COD removal efficiency. The results showed that the use of the PDA-modified membrane and a mixture of catalysts facilitated the transfer of cations released during the oxidation process in the anodic compartment of the MFC, which increased the power generation in the MFC by 2.5 times and 5.7 times the current compared to pristine and PDA pristine membranes, decreased the MFC operating cycle time from 5 to 3 days, doubled the lifetime of the membranes and demonstrated higher COD removal efficiency and color removal. Finally, SEM and AFM analysis showed that the modification significantly minimized surface fouling. The modified membranes in this study proved to be a potential alternative to the expensive membranes currently used in MFCs, furthermore, this modification could be an interesting alternative modification for other potential membranes for use in MFCs, due to the fact that the catalyst activation was only performed with visible light (artificial and solar), which could decrease operating costs.

First Lung Transplantation in Jehovah's Witness Patient in Latin America.

Lung transplantation is a life-saving alternative for patients with end-stage lung disease. The procedure itself has a high risk of bleeding. Jehovah's Witness patients refuse to accept blood products due to religious beliefs. A 48-year-old Jehovah's Witness woman presented with an 8-year history of cough, dyspnea along with progressive worsening of her functional class and quality of life. A diagnosis of autoimmune interstitial lung disease was made, for which cyclophosphamide was administered without improvement of symptoms, and the patient was accepted as a transplant candidate. Transplantation was performed without complications, nor blood products requirement, intraoperative cell salvage was performed, and pharmacological agents were used preoperatively for bleeding prevention. The patient only developed anemia after administration of immunosuppressor therapy, which was treated with erythropoietin in the outpatient setting.